NVT vs. BBIO
NVT (nVent Electric plc) and BBIO (BridgeBio Pharma, Inc.) are both stocks. NVT operates in Electrical Equipment & Parts (Industrials), while BBIO operates in Biotechnology (Healthcare). Over the past 5 years, NVT returned 41.15%/yr vs 0.88%/yr for BBIO. At a 0.27 correlation, their price movements are largely independent.
Performance
NVT vs. BBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVT achieves a 63.18% return, which is significantly higher than BBIO's -12.67% return.
NVT
- 1D
- 0.80%
- 1M
- -4.09%
- YTD
- 63.18%
- 6M
- 63.60%
- 1Y
- 139.62%
- 3Y*
- 52.46%
- 5Y*
- 41.15%
- 10Y*
- —
BBIO
- 1D
- -1.11%
- 1M
- -2.64%
- YTD
- -12.67%
- 6M
- -11.11%
- 1Y
- 68.47%
- 3Y*
- 58.58%
- 5Y*
- 0.88%
- 10Y*
- —
NVT vs. BBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
NVT nVent Electric plc | 63.18% | 51.27% | 16.63% | 55.98% | 3.32% | 67.15% | -5.68% | 4.85% |
BBIO BridgeBio Pharma, Inc. | -12.67% | 178.75% | -32.03% | 429.79% | -54.32% | -76.54% | 102.88% | 14.51% |
Correlation
The correlation between NVT and BBIO is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Jun 27, 2019 | 0.27 |
Fundamentals
NVT:
$27.20B
BBIO:
$13.01B
NVT:
$3.00
BBIO:
-$3.76
NVT:
6.29
BBIO:
22.81
NVT:
$4.33B
BBIO:
$566.04M
NVT:
$1.60B
BBIO:
$538.20M
NVT:
$857.60M
BBIO:
-$602.24M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVT vs. BBIO — Risk / Return Rank
NVT
BBIO
NVT vs. BBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for nVent Electric plc (NVT) and BridgeBio Pharma, Inc. (BBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVT | BBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.93 | ||
| Sortino ratioReturn per unit of downside risk | +1.73 | ||
| Omega ratioGain probability vs. loss probability | 1.51 | 1.29 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 8.30 | 3.40 | +4.90 |
| Martin ratioReturn relative to average drawdown | 28.25 | 8.27 | +19.98 |
Loading charts...
Drawdowns
NVT vs. BBIO - Drawdown Comparison
The maximum NVT drawdown since its inception was -56.18%, smaller than the maximum BBIO drawdown of -92.80%. Use the drawdown chart below to compare losses from any high point for NVT and BBIO.
Loading charts...
Drawdown Indicators
| NVT | BBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -56.18% | -92.80% | +36.62% |
Max Drawdown (1Y)Largest decline over 1 year | -16.93% | -20.25% | +3.32% |
Max Drawdown (3Y)Largest decline over 3 years | -46.67% | -49.08% | +2.41% |
Max Drawdown (5Y)Largest decline over 5 years | -46.67% | -91.89% | +45.22% |
Current DrawdownCurrent decline from peak | -5.98% | -16.41% | +10.43% |
Average DrawdownAverage peak-to-trough decline | -11.82% | -45.77% | +33.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.96% | 8.31% | -3.35% |
Volatility
NVT vs. BBIO - Volatility Comparison
nVent Electric plc (NVT) has a higher volatility of 12.76% compared to BridgeBio Pharma, Inc. (BBIO) at 10.47%. This indicates that NVT's price experiences larger fluctuations and is considered to be riskier than BBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVT | BBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.76% | 10.47% | +2.29% |
Volatility (6M)Calculated over the trailing 6-month period | 32.57% | 34.18% | -1.61% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.19% | 46.52% | -5.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.06% | 85.91% | -49.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.49% | 83.77% | -45.28% |
Dividends
NVT vs. BBIO - Dividend Comparison
NVT's dividend yield for the trailing twelve months is around 0.49%, while BBIO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BBIO BridgeBio Pharma, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVT nVent Electric plc | 0.49% | 0.78% | 1.12% | 1.18% | 1.82% | 1.84% | 3.01% | 2.74% | 1.56% |
Financials
NVT vs. BBIO - Financials Comparison
This section allows you to compare key financial metrics between nVent Electric plc and BridgeBio Pharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVT vs. BBIO - Profitability Comparison
NVT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, nVent Electric plc reported a gross profit of 445.60M and revenue of 1.24B. Therefore, the gross margin over that period was 35.9%.
BBIO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported a gross profit of 178.39M and revenue of 180.60M. Therefore, the gross margin over that period was 98.8%.
NVT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, nVent Electric plc reported an operating income of 195.70M and revenue of 1.24B, resulting in an operating margin of 15.8%.
BBIO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported an operating income of -105.96M and revenue of 180.60M, resulting in an operating margin of -58.7%.
NVT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, nVent Electric plc reported a net income of 142.40M and revenue of 1.24B, resulting in a net margin of 11.5%.
BBIO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported a net income of -164.04M and revenue of 180.60M, resulting in a net margin of -90.8%.
Frequently Asked Questions
NVT and BBIO have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVT has higher volatility (12.76%) compared to BBIO (10.47%). In terms of maximum drawdown, NVT dropped -56.18% vs BBIO's -92.80%.
NVT currently has the higher Sharpe Ratio (3.41 vs 1.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVT and BBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer